Promising Efficacy of Biologicals and Small Molecules for Microscopic Colitis
The study presented in this MEDtalk by Bram Verstockt aimed to evaluate the efficacy of advanced therapies in treating microscopic colitis, particularly in patients who are refractory to or dependent on budesonide, the only approved therapy with a high relapse rate and significant side effects.
